GRI Bio, Inc. (NASDAQ:GRI – Free Report) – Research analysts at HC Wainwright upped their Q3 2026 earnings per share (EPS) estimates for GRI Bio in a report issued on Thursday, September 10th. HC Wainwright analyst M. Keller now anticipates that the company will post earnings of ($0.75) per share for the quarter, up from […]